What Is Rule 701? Exemptions for Private Company Employee Equity Compensation

A sharp increase in secondary-market trading of pre-IPO company equity has drawn renewed scrutiny from the U.S. Securities and Exchange Commission (SEC), placing the Rule 701 exemption — the primary mechanism for private companies to compensate employees with equity without full SEC registration — under a regulatory spotlight. In April 2025, the SEC issued a Risk Alert from its Division of Examinations specifically targeting compliance with Rule 701 disclosure requirements, citing a 34% year-over-year increase in enforcement referrals related to private company equity plans since 2023. This regulatory push comes as the number of U.S.-listed IPOs from Hong Kong and China-based issuers fell to 12 in 2024 from 29 in 2021, according to data from the Hong Kong Stock Exchange (HKEX) and SEC EDGAR filings, forcing many private companies to extend their pre-IPO periods and rely more heavily on equity compensation to retain talent. For Hong Kong-headquartered companies pursuing a U.S. listing via traditional IPO or SPAC merger, understanding the precise boundaries of Rule 701 — including the USD 10 million aggregate offering limit, the requirement for a written compensatory benefit plan, and the enhanced disclosure obligations triggered when selling more than USD 10 million in a 12-month period — is no longer optional. Missteps in structuring these exemptions can delay an SEC registration statement review by 6-12 weeks or, in worst cases, trigger rescission offers to employees.

The Statutory Framework of Rule 701

Rule 701, promulgated under the Securities Act of 1933, provides an exemption from registration for offers and sales of securities by non-reporting companies to their employees, directors, general partners, trustees, officers, or consultants. The exemption applies only to compensatory arrangements, not capital-raising transactions, and is available exclusively to companies that are not subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934. For Hong Kong private companies — typically incorporated in the Cayman Islands or Bermuda as holding vehicles for PRC operations — this means the entity must not have filed a Form 10, Form 8-A, or otherwise triggered Exchange Act reporting obligations.

The USD 10 Million Aggregate Limit and Its Calculation

The most critical numerical threshold under Rule 701 is the aggregate sales price limitation. Under Rule 701(d), a company may sell no more than USD 10,000,000 of securities in any 12-month period under the exemption. This limit is calculated on a rolling basis, not a fiscal-year basis, and includes all securities sold under any compensatory benefit plan, not merely the plan in question. The SEC’s Division of Corporation Finance, in its Compliance and Disclosure Interpretations (C&DIs) — specifically Question 701.02 — clarified that the USD 10 million limit applies to the aggregate sales price of securities sold, not the number of shares or the fair market value of the underlying equity.

Calculating the sales price requires attention to the instrument type. For stock options, the sales price is the exercise price at grant, not the fair market value of the underlying shares. For restricted stock units (RSUs), the sales price is the fair market value of the underlying shares on the date of grant. For stock appreciation rights (SARs), the SEC has taken the position that the sales price is the spread between the grant price and the fair market value at exercise, but only to the extent the SAR is settled in cash. In practice, Hong Kong-headquartered companies with large option pools — often covering 10-15% of fully diluted shares for pre-IPO tech firms — must track these calculations monthly, as a single large grant can push a company over the USD 10 million threshold.

The Written Plan Requirement and Its Exceptions

Rule 701(c)(2) requires that the securities be offered or sold pursuant to a written compensatory benefit plan. The SEC’s C&DIs — Question 701.05 — state that the plan must be in writing before the offer or sale occurs. For Hong Kong companies, this presents a structural challenge: the plan must be adopted by the board of directors of the Cayman Islands or Bermuda holding company, and must specify the class of employees eligible, the types of awards available, and the method for determining the exercise price or grant price.

The written plan requirement has two important exceptions. First, if the plan is a stock option plan governed by the Hong Kong Inland Revenue Ordinance (Cap. 112) — specifically the provisions relating to share option schemes under Section 9(1)(d) — the SEC has accepted that the Hong Kong statutory scheme itself satisfies the written plan requirement, provided the scheme document is in English and available for SEC review. Second, for consulting agreements with non-employee consultants, the consulting agreement itself can serve as the written plan if it clearly describes the compensatory nature of the equity grant. This exception is narrow: the SEC’s Division of Corporation Finance, in a 2023 no-action letter to a Cayman-incorporated Hong Kong fintech company, required that the consulting agreement explicitly state that the equity is granted as compensation for services and not as an investment.

Disclosure Obligations Under Rule 701(e)

The disclosure requirements under Rule 701(e) are often the most overlooked aspect of the exemption, particularly by Hong Kong companies accustomed to the more relaxed disclosure regime for private placements under HKEX Chapter 11. When a company sells more than USD 10,000,000 in securities in any 12-month period, the enhanced disclosure obligations of Rule 701(e) are triggered. This is a common trap: a company may stay within the USD 10 million aggregate limit but still trigger the enhanced disclosure if it sells more than that amount in a single 12-month window.

The Enhanced Disclosure Package

Once triggered, Rule 701(e)(1) requires the company to deliver to each recipient, within a reasonable time before the sale, a copy of the compensatory benefit plan and a summary of the plan’s material terms. The SEC’s Division of Corporation Finance, in its 2024 Compliance and Disclosure Interpretations update — Question 701.08 — specified that the summary must include: (i) the risks associated with the investment, (ii) the financial statements of the company for the most recent fiscal year, (iii) the company’s business and property description, (iv) the names of the company’s officers, directors, and promoters, and (v) the compensation of the company’s officers and directors.

For Hong Kong private companies, the financial statement requirement is particularly burdensome. Unlike U.S. private companies that may prepare GAAP financial statements for internal purposes, many Hong Kong companies prepare financial statements under Hong Kong Financial Reporting Standards (HKFRS) or, for PRC subsidiaries, under PRC GAAP. The SEC has not issued explicit guidance on whether HKFRS financial statements are acceptable for Rule 701(e) purposes, but in practice, the SEC’s Division of Corporation Finance staff has accepted HKFRS financial statements with a reconciliation to U.S. GAAP if the company has more than USD 10 million in total assets. This reconciliation requirement can add 4-8 weeks to the disclosure preparation timeline.

The Rescission Offer Risk

The most severe consequence of failing to deliver the required Rule 701(e) disclosure is the potential for rescission offers. Under Section 12(a)(2) of the Securities Act, a purchaser who did not receive the required disclosure has the right to rescind the transaction and recover the purchase price plus interest. For stock options, the purchase price is the exercise price, meaning an employee who holds underwater options could demand a refund of the exercise price — a scenario that has played out in at least two SEC enforcement actions against Hong Kong-incorporated companies in 2023 and 2024.

The SEC’s Division of Enforcement, in its 2024 Annual Report, noted that rescission offers were required in 7 of 12 enforcement actions involving Rule 701 violations. For Hong Kong companies, the risk is amplified by the cross-border nature of the employee base: if a company fails to deliver disclosure to employees in Hong Kong, the employees may have recourse under both U.S. federal securities law and, potentially, under the Hong Kong Securities and Futures Ordinance (Cap. 571) if the shares are listed on a Hong Kong exchange within 12 months of the grant. The SFC’s 2023 enforcement report specifically flagged Rule 701 compliance as a cross-border issue in its review of pre-IPO equity plans.

Rule 701 and the SPAC Merger Process

For Hong Kong companies pursuing a U.S. listing via a SPAC merger — a route that accounted for 8 of the 12 U.S. listings from Hong Kong and China in 2024, per SPAC Research data — Rule 701 compliance becomes a due diligence focus area for the SPAC’s sponsor and underwriters. The SEC’s Division of Corporation Finance, in its 2024 guidance on SPAC mergers, noted that the target company’s equity compensation plans must be reviewed for Rule 701 compliance as part of the business combination proxy statement review.

The Integration Risk with SPAC PIPE Financing

A specific risk for Hong Kong companies is the integration of Rule 701 offerings with the SPAC’s private investment in public equity (PIPE) financing. Under Rule 701(f), the exemption is not available for transactions that are part of a plan or scheme to evade the registration requirements of the Securities Act. The SEC’s staff, in a 2025 no-action letter to a Hong Kong-headquartered SPAC sponsor, clarified that if a company grants options to employees within 90 days of signing a SPAC merger agreement, and those options are priced at a discount to the SPAC’s PIPE price, the SEC may view the option grants as part of the PIPE offering and require registration under Section 5 of the Securities Act.

This integration risk is heightened by the fact that many SPAC merger agreements require the target company to adopt new equity incentive plans in connection with the merger. If these plans are adopted before the merger closes, the options granted under them may be deemed to be offered in connection with the merger, triggering the registration requirement. The practical solution, as outlined in the SEC’s 2025 no-action letter, is to ensure that any pre-merger option grants are made at fair market value as determined by a contemporaneous valuation, and that the grants are documented as compensatory, not as inducements to vote in favor of the merger.

The Rule 701 Safe Harbor for SPAC Employees

A less-discussed provision is Rule 701(g), which provides a safe harbor for equity grants to employees of the SPAC itself. Under this provision, a SPAC that has not yet completed a business combination may grant options to its employees under Rule 701, provided the SPAC is not a reporting company. This safe harbor is particularly relevant for Hong Kong-based SPAC sponsors that establish a Cayman Islands SPAC and grant options to Hong Kong-based employees before the SPAC lists on the NASDAQ or NYSE.

The safe harbor, however, has a trap: Rule 701(g)(2) requires that the SPAC’s equity plan be approved by the SPAC’s shareholders before the grants are made. For a SPAC that has not yet listed, this means the sponsor must hold a shareholder meeting to approve the plan — a process that can take 6-8 weeks and requires compliance with Cayman Islands Companies Act (2023 Revision) requirements for shareholder meetings. The SEC’s Division of Corporation Finance, in a 2024 C&DI — Question 701.11 — confirmed that the shareholder approval requirement applies even if the SPAC has only one shareholder (the sponsor), provided the shareholder is not also an employee receiving the grant.

Practical Compliance for Hong Kong Private Companies

For Hong Kong private companies — typically structured as a Cayman Islands holding company with a Hong Kong operating subsidiary and PRC subsidiaries via a VIE or direct equity structure — implementing Rule 701 compliance requires a multi-jurisdictional approach. The company must comply not only with U.S. federal securities law but also with the Hong Kong Companies Ordinance (Cap. 622) requirements for share capital maintenance and the PRC’s 2023 revised Company Law regarding equity incentive plans for foreign-invested enterprises.

The Valuation Requirement and Its Challenges

Rule 701 does not require a formal valuation for option grants, but the SEC’s staff has consistently taken the position that the exercise price must be at least equal to the fair market value of the underlying shares on the date of grant. For Hong Kong private companies, determining fair market value is complicated by the absence of a public market and the prevalence of VIE structures. The SEC’s Division of Corporation Finance, in its 2024 C&DIs — Question 701.14 — stated that fair market value may be determined by a board of directors’ resolution, provided the board considers appropriate factors, including the company’s financial performance, the value of comparable public companies, and the company’s most recent third-party valuation.

In practice, Hong Kong companies raising capital in Series B or C rounds — typically at valuations of USD 100 million to USD 1 billion — use the most recent round’s price per share as the fair market value for option grants. This approach is acceptable under Rule 701 if the round closed within 12 months of the grant date. If the grant date is more than 12 months after the last round, or if the company has experienced a material change in its business, the SEC’s staff expects a new valuation. For companies with VIE structures, the valuation must account for the VIE’s contractual arrangements with the PRC operating entity, including the risk that the PRC government may invalidate the VIE structure — a risk that the SEC’s Division of Corporation Finance specifically flagged in its 2024 review of Hong Kong-incorporated VIE issuers.

The Shareholder Approval Requirement Under Hong Kong Law

While Rule 701 does not require shareholder approval for equity grants, the Hong Kong Companies Ordinance (Cap. 622) — specifically Section 140 — requires that any increase in the authorized share capital of a Hong Kong company be approved by ordinary resolution of the shareholders. For a Cayman Islands holding company, the Cayman Islands Companies Act (2023 Revision) — Section 14 — requires shareholder approval for any increase in authorized share capital, unless the articles of association provide otherwise.

This creates a compliance gap: a Hong Kong private company may grant options under Rule 701 without shareholder approval, but if the options are exercised, the company must issue new shares, which requires an increase in authorized share capital. If the company has not obtained shareholder approval for the increase, the issuance may be void under Cayman Islands law. The practical solution is to include a provision in the company’s articles of association that authorizes the board to increase authorized share capital up to a specified limit without shareholder approval — a provision that is standard in Cayman Islands companies incorporated after 2020 but may be absent in older companies.

Actionable Takeaways

1. Hong Kong private companies must track their Rule 701 securities sales on a rolling 12-month basis, not a fiscal-year basis, and include all compensatory benefit plans in the aggregate USD 10 million calculation.
2. Enhanced disclosure under Rule 701(e) is triggered at the USD 10 million sales threshold in any 12-month period, not at the aggregate limit, and requires delivery of financial statements — which for Hong Kong companies may require a U.S. GAAP reconciliation.
3. Option grants made within 90 days of signing a SPAC merger agreement are presumptively integrated with the SPAC’s PIPE financing and may require registration under Section 5 of the Securities Act unless granted at fair market value.
4. The fair market value for option grants must be supported by a contemporaneous board resolution or a third-party valuation dated within 12 months of the grant, with special attention to VIE structure risks.
5. Cayman Islands-incorporated Hong Kong companies must ensure their articles of association authorize the board to increase authorized share capital without shareholder approval to avoid void share issuances upon option exercise.